<DOC>
	<DOCNO>NCT01314482</DOCNO>
	<brief_summary>In half patient open chest surgery persistent severe pain chest . The investigator examine whether minocycline , commonly use antibiotic , prevent pain . Minocycline block activity immune cell investigator believe responsible prolonging pain .</brief_summary>
	<brief_title>Minocycline Prevention Post-operative Intercostal Neuralgia</brief_title>
	<detailed_description>The study double-blind placebo control parallel group design 116 patient undergoing elective open thoracotomy . Minocycline 200mg twice daily match placebo give three day surgery .</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<criteria>Male female Aged 18 year old Undertaking elective , open thoracotomy ample time preoperatively provide informed consent undertake dose Sufficient fluency English language read understand consent form , fulfil study requirement communicate research staff Negative pregnancy test screen woman child bear potential Females child bear potential must agree use medically acceptable method contraception oral contraceptive time first dose one week postoperatively . Acceptable method include abstinence , contraceptive patch , NuvaRing ( etonogestrel/ethinyl oestradiol vaginal ring ) , diaphragm vaginal spermicide , intrauterine device , condom vaginal spermicide , progestin implant injection Avoid prolong , direct sunlight ultraviolet light exposure dose period Refrain strenuous activity avoid change regular exercise pattern throughout trial period Pregnant breast feed Known allergy minocycline tetracycline antibiotic Preexisting neuralgic pain condition area designate operation Physical abnormality area designate operation Taking disallow concomitant medication Renal insufficiency determine calculated creatinine clearance &lt; 60mL/min Hepatic dysfunction determine alanine transaminase and/or aspartate transaminase excess three time upper normal limit Diagnosis systemic lupus erythematosus Recent diagnosis enterocolitis colitis Participation another trial investigational product within 30 day commence dose schedule commence trial investigational product study period Patients , Investigator 's opinion , participate trial may capable follow trial schedule reason History major psychiatric disorder medically control</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Neuropathic pain</keyword>
	<keyword>Minocycline</keyword>
</DOC>